Compare Tenet Healthcare Corporation (THC) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Verisign, Inc. — how do they compare? Tenet Healthcare Corporation trades at $262.03 (market cap $20.98B), while Verisign, Inc. trades at $297.8 (market cap $26.92B). The key difference: Verisign, Inc. is the larger of the two by market cap, and Verisign, Inc. pays a 1.09% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Verisign, Inc. for 123 Days on average.
| THC | VRSN | |
|---|---|---|
Market Cap | $20.98B | $26.92B |
Volume | 428,008 | 1,921,402 |
Sector | Health | Technology |
52-Week High | $280.77 | $310.00 |
52-Week Low | $161.37 | $211.49 |
Typical Hold Time | 15 Days | 123 Days |
Enterprise Value | $32.06B | $28.23B |
Dividend Yield | — | 1.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
VeriSign (VRSN) trades at $294.22, up 0.38% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $348. The company reported strong 2025 results with $1.66 billion in revenue and a net income margin near 50%, though recent quarterly EPS results have been mixed. Positive sentiment is driven by record domain registrations and institutional buying, while an antitrust lawsuit presents a notable risk.
The stock offers upside potential based on analyst targets, supported by stable cash flow and high profitability. Key risks include legal challenges and competitive pressures. The upcoming Q3 2026 earnings report on October 22 will be critical for validating growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
